Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Product Liability Law & StrategyKickerFeaturesTopicsLitigationSectionsNewsLJN Newsletters

Forum Non Conveniens

By James J. 'J.' Ferrelli
September 28, 2007
On July 31, 2007, the Appellate Division of the New Jersey Superior Court affirmed the forum non conveniens dismissal of pharmaceutical product liability claims filed by 95 UK plaintiffs in In re Vioxx Litigation, Docket No. A-1731-06T1. The case involved allegations asserting personal injury claims allegedly caused by defendant Merck & Co., Inc.'s anti-inflammatory medicine, Vioxx'. This is a noteworthy forum non conveniens decision that could well have ramifications outside of New Jersey, particularly in other mass tort situations.

The court applied the forum non conveniens doctrine set forth in Gulf Oil Corp. v. Gilbert, 330 U.S. 501 (1947), which was adopted in New Jersey in Gore v. U.S. Steel Corp., 15 N.J. 301 (1954). First, the court found that the UK was an adequate alternative forum for these plaintiffs, rejecting plaintiffs' argument that their inability to recover identical damages in the UK, including punitive damages, and other factors, made the UK an inadequate alternative forum. Second, balancing the parties' 'private interest' factors, the court found them to be 'geographically divided,' and not dispositive of Merck's burden of showing that the New Jersey forum is 'demonstrably inappropriate.'

Finally, the court held that the 'public interest' factors were decisive. It was likely that UK law would apply to issues relating to product approval and labeling, which occurred in the UK. Further, the UK forum had a 'distinctive' interest in adjudicating a case involving a prescription drug that was subject to UK regulatory approval, and was sold and ingested in the UK. The UK also had a strong interest in addressing the injuries of its citizens that occurred within its borders. While New Jersey has an interest in regulating the conduct of New Jersey-domiciled corporations, the court held that New Jersey's interest would be 'well-satisfied' through litigation of the 15,000 Vioxx suits filed by U.S. residents that were pending in New Jersey.

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.

Compliance Officers: Recent Regulatory Guidance and Enforcement Actions and Mitigating the Risk of Personal Liability Image

This article explores legal developments over the past year that may impact compliance officer personal liability.